Source published October 2, 2026. Research-organization partnership announcement. Added to Neurofeedback.com October 5, 2026.
HITLAB and MiraWell have announced a partnership to evaluate a platform combining immersive extended reality, biofeedback and real-time physiological signals for pain and stress care. The platform originated from work by pediatricians addressing gaps in options for young patients, according to the announcement.
The useful advance is a commitment to evaluation before wider adoption. Testing whether feedback-guided immersive experiences help patients could give families and clinicians a firmer basis for decisions.
This announcement does not report a completed clinical trial, participant numbers, a comparator, measured benefits or adverse-event results. It does not establish regulatory clearance. The assessment methods and outcomes will matter more than the promise of the technology.
HITLAB is announcing its own partnership; MiraWell is a commercial platform supported by Boomerang Ventures. Evaluation funding terms are not disclosed in the release.
AI-assisted source review and summary; no human clinical review is implied. The image is an AI-generated conceptual illustration, not MiraWell equipment or a research result.